The exclusive right grants Cellular Engineering Technologies the intellectual property to develop, manufacture and commercialize next generation bio-production of recombinant proteins, viral vectors for gene therapy and vaccines with more a more native human post-translational modification (PTM). Coralville, Iowa, 6 March 2023: Cellular Engineering Technologies (CET), Inc., an Iowa biotechnology company specializing in cell manufacturing and … Read more